European Biotech Acquisition Corp.
| General Information | |
| Business: | We intend to capitalize on the ability of our management team to identify promising opportunities in the life sciences industry in Europe. (Blank check company incorporated in the Cayman Islands) (Note: European Biotech Acquisition priced its SPAC IPO on March 15, 2021, in sync with the terms in its prospectus: 10 million units at $10 each to raise $100 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2021 |
| Contact Information | |
| Address | Johannes Vermeerplein 9 1071 DV Amsterdam, Netherlands |
| Phone Number | 31 (0) 20 664 55 00 |
| Web Address | |
| View Prospectus: | European Biotech Acquisition Corp. |
| Financial Information | |
| Market Cap | $129.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | EBACU |
| Exchange | NASDAQ |
| Shares (millions): | 10.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $100.0 mil |
| Manager / Joint Managers | Credit Suisse/Kempen & Co. |
| CO-Managers | - |
| Expected To Trade: | 3/16/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |